Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Characterization of four novel epithelial ovarian cancer cell lines.

Literature DB >> 10949993

Characterization of four novel epithelial ovarian cancer cell lines.

D M Provencher, H Lounis, L Champoux, M Tétrault, E N Manderson, J C Wang, P Eydoux, R Savoie, P N Tonin, A M Mes-Masson.

Abstract

Entities: CellLine Disease

Mesh：

Substances：

Year: 2000 PMID： 10949993 DOI： 10.1290/1071-2690(2000)036<0357:COFNEO>2.0.CO;2

Source DB: PubMed Journal: In Vitro Cell Dev Biol Anim ISSN： 1071-2690 Impact factor: 2.416

× No keyword cloud information.

31 in total

1. Establishment and characterization of three new cell lines derived from the ascites of human ovarian carcinomas.

Authors: A Alama; F Barbieri; A Favre; M Cagnoli; E Noviello; F Pedullà; M Viale; G Foglia; N Ragni
Journal: Gynecol Oncol Date: 1996-07 Impact factor: 5.482

2. Discordance in p53 mutations when comparing ascites and solid tumors from patients with serous ovarian cancer.

Authors: D M Provencher; H Lounis; D Fink; P Drouin; A M Mes-Masson
Journal: Tumour Biol Date: 1997

3. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors: D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal: Science Date: 1989-05-12 Impact factor: 47.728

4. Establishment and characterization of two new human ovarian cancer cell lines UWOV1 and UWOV2 and a subline UWOV2 (Sf) growing in serum-free conditions: growth characteristics, biochemical, and cytogenetic studies.

Authors: T Golombick; R Dansey; W R Bezwoda; J Rosendorff
Journal: In Vitro Cell Dev Biol Date: 1990-05

5. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

Authors: D F Easton; D T Bishop; D Ford; G P Crockford
Journal: Am J Hum Genet Date: 1993-04 Impact factor: 11.025

6. Comparison of antigen expression on fresh and cultured ascites cells and on solid tumors of patients with epithelial ovarian cancer.

Authors: D M Provencher; C L Finstad; P E Saigo; S C Rubin; W J Hoskins; M G Federici; E Stockert; K O Lloyd; J L Lewis
Journal: Gynecol Oncol Date: 1993-07 Impact factor: 5.482

7. Isolation and preliminary characterization of an ovarian carcinoma cell line from a patient with familial ovarian cancer.

Authors: R E Buller; T Niemann; J P Connor; R C Squatrito; J S Skilling; B Anderson
Journal: Gynecol Oncol Date: 1995-01 Impact factor: 5.482

8. Overexpression of her-2/neu in human prostate cancer and benign hyperplasia.

Authors: K Gu; A M Mes-Masson; J Gauthier; F Saad
Journal: Cancer Lett Date: 1996-02-06 Impact factor: 8.679

9. Monoclonal antibodies to three widely distributed human cell surface antigens.

Authors: M J Mattes; J G Cairncross; L J Old; K O Lloyd
Journal: Hybridoma Date: 1983

10. Different propensity for spontaneous differentiation of cell clones isolated from the human ovarian surface epithelial cell line HOC-7.

Authors: T W Grunt; H Oeller; C Somay; C Dittrich
Journal: Differentiation Date: 1993-05 Impact factor: 3.880

78 in total

1. Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.

Authors: Emily N Manderson; Anne-Marie Mes-Masson; Jaroslav Novak; Peter D Lee; Diane Provencher; Thomas J Hudson; Patricia N Tonin
Journal: Genome Res Date: 2002-01 Impact factor: 9.043

2. Alterations in nuclear pore architecture allow cancer cell entry into or exit from drug-resistant dormancy.

Authors: Yayoi Kinoshita; Tamara Kalir; Jamal Rahaman; Peter Dottino; D Stave Kohtz
Journal: Am J Pathol Date: 2011-11-07 Impact factor: 4.307

Review 3. Epithelial ovarian cancer experimental models.

Authors: E Lengyel; J E Burdette; H A Kenny; D Matei; J Pilrose; P Haluska; K P Nephew; D B Hales; M S Stack
Journal: Oncogene Date: 2013-08-12 Impact factor: 9.867

4. A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer.

Authors: Hsin-Yao Tang; Lynn A Beer; Tony Chang-Wong; Rachel Hammond; Phyllis Gimotty; George Coukos; David W Speicher
Journal: J Proteome Res Date: 2011-11-18 Impact factor: 4.466

5. Detection of novel biomarkers for ovarian cancer with an optical nanotechnology detection system enabling label-free diagnostics.

Authors: Simon Kaja; Jill D Hilgenberg; Julie L Collins; Anna A Shah; Debra Wawro; Shelby Zimmerman; Robert Magnusson; Peter Koulen
Journal: J Biomed Opt Date: 2012-08 Impact factor: 3.170

10. Comparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysis.

Authors: Lan Dai; Chen Li; Kerby A Shedden; David E Misek; David M Lubman
Journal: Electrophoresis Date: 2009-04 Impact factor: 3.535